BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8325034)

  • 1. Primary IgA glomerulonephritis and MHC revisited.
    Berthoux FC; Alamartine E; Laurent B; Berthoux P; Vacherot C; Lambert C; Le Petit JC
    Contrib Nephrol; 1993; 104():54-60. PubMed ID: 8325034
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA nephropathy: immunogenetic studies of Australian patients.
    Knight JF; Falk MC; Ng C; Fanning GC; Artlett CM; Roy LP
    Contrib Nephrol; 1995; 111():18-23. PubMed ID: 7758340
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA molecules and genes in primary IgA nephritis with end-stage renal failure.
    Berthoux P; el Deeb S; Boulharouz R; Cecillon S; Le Petit JC; Berthoux FC
    Contrib Nephrol; 1995; 111():24-8. PubMed ID: 7758343
    [No Abstract]   [Full Text] [Related]  

  • 4. MHC gene polymorphism in primary IgA nephropathy.
    Moore R
    Kidney Int Suppl; 1993 Jan; 39():S9-12. PubMed ID: 8468933
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure.
    Doxiadis II; De Lange P; De Vries E; Persijn GG; Claas FH
    Tissue Antigens; 2001 Apr; 57(4):344-7. PubMed ID: 11380944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic study on HLA class II and class III region in the disease associated with IgA nephropathy.
    Abe J; Kohsaka T; Tanaka M; Kobayashi N
    Nephron; 1993; 65(1):17-22. PubMed ID: 8105396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and IgA nephritis revisited 10 years later: HLA-B35 antigen as a prognostic factor.
    Berthoux FC; Alamartine E; Pommier G; Lepetit JC
    N Engl J Med; 1988 Dec; 319(24):1609-10. PubMed ID: 3264381
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
    Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
    [No Abstract]   [Full Text] [Related]  

  • 9. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
    Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA DQ region gene polymorphism associated with primary IgA nephropathy.
    Moore RH; Hitman GA; Lucas EY; Richards NT; Venning MC; Papiha S; Goodship TH; Fidler A; Awad J; Festenstein H
    Kidney Int; 1990 Mar; 37(3):991-5. PubMed ID: 1968992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of HLA-DR4 in the long-term prognosis of IgA nephropathy.
    Hiki Y; Kobayashi Y; Ookubo M; Kashiwagi N
    Nephron; 1990; 54(3):264-5. PubMed ID: 2314543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene and gliadin/gut and kidney.
    Biagi F; Corazza GR
    Am J Gastroenterol; 2002 Oct; 97(10):2486-8. PubMed ID: 12385427
    [No Abstract]   [Full Text] [Related]  

  • 13. IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives.
    Waldo FB; Beischel L; West CD
    Kidney Int; 1986 Jun; 29(6):1229-33. PubMed ID: 3747336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement 4 locus II gene deletion and DQA1*0301 gene: genetic risk factors for IgA nephropathy and Henoch-Schönlein nephritis.
    Jin DK; Kohsaka T; Koo JW; Ha IS; Cheong HI; Choi Y
    Nephron; 1996; 73(3):390-5. PubMed ID: 8832595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and Chinese IgA nephropathy in Taiwan.
    Huang CC; Hu SA; Lin JL; Wu JH
    Tissue Antigens; 1989 Jan; 33(1):45-7. PubMed ID: 2785299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and hypocomplementemia: the disadvantage of carrying the HLA-B35 and the silent alleles of the C4 complement component.
    Zorzetto M; Ricevuti G; Martinetti M; Gritti D; Gasparetto C; De Silvestri A; Salvaneschi L; Cuccia M
    Int J Immunopathol Pharmacol; 2004; 17(3):307-16. PubMed ID: 15461865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HLA haplotypes associated with IgA nephropathy].
    Ito H
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):273-80. PubMed ID: 8501857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class III (C2, C4, factor B) and C3 gene variants in patients with pulmonary tuberculosis.
    Senbagavalli P; Kumar N; Kaur G; Mehra NK; Geetha ST; Ramanathan VD
    Hum Immunol; 2011 Feb; 72(2):173-8. PubMed ID: 21093518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus.
    Fronek Z; Timmerman LA; Alper CA; Hahn BH; Kalunian K; Peterlin BM; McDevitt HO
    Arthritis Rheum; 1990 Oct; 33(10):1542-53. PubMed ID: 1977392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DQ associations in type 1 autoimmune hepatitis.
    Czaja AJ; Santrach PJ; Moore SB
    Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.